eli lilly tirzepatide - Search News

Cipla, Eli Lilly and type 2 diabetes

Stocktwits on MSN · 2d

Cipla Shares Fall To Biggest Intra-day Lows In Six Months Despite Eli Lilly Deal For Diabetes Drug

Cipla-Eli Lilly partner to distribute Tirzepatide under the Yurpeak brand in India ・Tirzepatide is used to manage type 2 diabetes and chronic weight issues in adults ・The stock has outperformed the broader pharma index YTD Shares of Cipla fell 3.

Continue reading

· 3d · on MSN

Eli Lilly gives Cipla license to sell weight-loss drug Tirzepatide in India

Medical Dialogues · 2d

Eli Lilly's Diabetes Drug Mounjaro Gets Second Brand Yurpeak via Cipla Deal

The Pharma Letter

Cipla and Eli Lilly partner to launch tirzepatide as Yurpeak in India

Indian drugmaker Cipla Limited has entered into a strategic marketing and distribution agreement with US pharma major Eli ...

4don MSN

3 Things Investors Need to Know Ahead of Eli Lilly's Q3 Earnings Report

On Oct. 30, Eli Lilly will announce third-quarter earnings results that could lift the stock, or pressure it further. Here ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results